Patient Engagement Needs 'Regulatory Guardrails' To Encourage Firms, Advocates Say
This article was originally published in The Pink Sheet Daily
Executive Summary
Guidance development initiative led by National Health Council and Genetic Alliance will propose to FDA ways to de-risk industry efforts to get patients involved in drug development process.